Livea review
The medication figure and the program fee live on different pages, and the site says the relationship between them is settled at a consultation.
The verdict
Livea publishes compounded semaglutide starting at $99 a month and tirzepatide at $199, read July 2026, with a separate $69 monthly program fee disclosed on another page — which makes the real figures $168 and $268.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 4
- From
- $168/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 4 states
Livea sells both molecules by injection in four states, running a program fee covering consultation and supervision alongside a medication charge that is quoted separately.
Who writes the prescription, and what do they see?
The $69 program fee is described as covering consultation and supervision, which is a clearer statement of what a clinical relationship costs than most sellers offer. It is also on a different page from the price a reader arrives at.
Livea's own FAQ says whether the $99 is inclusive of or additive to the program fee is clarified at a free consultation. That is an unusual admission: the seller knows the question is open and has chosen to answer it in a call rather than in writing. The medical page describes the fee as covering program access and supervision with medication stated as separate, which is why this desk treats the two as additive.
What happens when the dose goes up?
Nothing is published about what the medication figure does at a higher dose. Livea also states that the end of the FDA shortage affects compounded tirzepatide availability and that it monitors eligibility, offering branded alternatives — so both the price and the supply of that line are conditional.
What the price includes
Adding the fee gives $168 a month for semaglutide and $268 for tirzepatide, and six months is $1,008 or $1,608. Budgeting from $99 would give $594, which is $414 short. The starting-at wording on both medication figures leaves a further gap on top of that.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing. The tirzepatide line's availability is stated to depend on compounding status.
Where it holds up, and where it does not
- Strength: The program fee is disclosed in writing
- Strength: What the fee covers is described
- Strength: Compounding-status risk is stated openly
- Limitation: The fee is on a different page from the price
- Limitation: The site defers the question to a call
- Limitation: Coverage is recorded in four states
- Limitation: Tirzepatide availability is conditional
What the evidence says about this kind of treatment
The assessment above is about Livea. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader in a served state who will get the fee relationship confirmed in writing.
- Wrong for
- A reader budgeting from the $99.
How Livea compares
| Seller | Who it suits | Go |
|---|---|---|
| Luma Meds | Readers who are new, will prepay three months, and know what month four costs | See Luma Meds → |
 Live Vital | Readers who work from the protocol total rather than the monthly figure beside it | See Live Vital → |
| LeanDose | Readers who will get the month-two rate in writing before the first charge | See LeanDose → |
More GLP-1 telehealth sellers reviews: Bon HealthBrello HealthCandor RxCeliaRxCitizen MedsClume Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Does $99 include the program fee?
- Livea's own FAQ says that is clarified at a free consultation. Its medical page describes the $69 fee as covering program access and supervision with medication separate, so the figures are treated here as additive: $168 a month.
- What does the $69 buy?
- Program access and supervision, including the consultation, per the medical page. Medication is stated separately.
- Is tirzepatide available?
- Conditionally. Livea states the end of the FDA shortage affects compounded tirzepatide and that it monitors eligibility, offering branded alternatives.
- Is Livea legit?
- Livea is a GLP-1 telehealth sellers service. Its stated availability: 4 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Livea expensive compared with other GLP-1 telehealth sellers?
- Livea publishes a starting figure of $168/mo. Across the 137 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $184, which puts Livea below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.